Stereotaxis Reports 2023 Second Quarter Financial Results
10 août 2023 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients
18 juil. 2023 09h18 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first...
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
17 juil. 2023 06h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis to Initiate First-in-Human Trial to Support CE Mark Application of MAGiC Catheter
15 juin 2023 16h10 HE
|
Stereotaxis, Inc.
ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
25 mai 2023 08h56 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Advocate Christ Medical Center Extends Leadership in Heart Care with Adoption of Genesis Robotic Technology
23 mai 2023 08h46 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 23, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the first treatment of...
Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
19 mai 2023 08h38 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’...
Stereotaxis Reports 2023 First Quarter Financial Results
09 mai 2023 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023
18 avr. 2023 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
Over 1,000 Cardiac Patients Treated with Genesis Robotic System
13 avr. 2023 09h06 HE
|
Stereotaxis, Inc.
ST. LOUIS, April 13, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that over...